Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in erosive hand osteoarthritis
2008-005365-61Phase 2Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in erosive hand osteoarthritis (EHOA) and hand osteoarthritis comparing Apremilast with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2009; status: completed.
02
Drugs
apremilast
03
Conditions
erosive hand osteoarthritis (EHOA)hand osteoarthritis
Beyond the preview
Go deeper on 2008-005365-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005365-61.